iRhythm’s $747M: Cardiac AI Dominance & Investor Playbook
The landscape of cardiac AI monitoring diagnostics is witnessing a significant inflection point, where technological innovation meets stringent…
Biofourmis, Oura: Investing in Always-On Cardiac AI Surveillance
The landscape of cardiac monitoring is undergoing a profound transformation, shifting from a reactive, episodic paradigm to one…
Viz.ai’s Billion Dollar Flight: Cracking Cardiac AI’s Unicorn Code
The valuation of Viz.ai at $1.2 billion USD represents a critical inflection point in the health AI landscape,…